Use access key #2 to skip to page content.
$23.91 0.59 (2.53%)
7/23/2008 4:00 PM

Abaxis, Inc. (ABAX)

CAPS Rating:
***

The Company develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.

X

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ABAX

Add Stock to Watchlist

What the Community Thinks

Total Members

120 Outperforms
14 Underperforms
 

All-Stars

29 Outperforms
5 Underperforms
 

Wall Street

2 Outperforms
1 Underperforms
 

Members bullish on ABAX are also bullish on:

Members bearish on ABAX are also bearish on:

Ticker Tags

Small Cap (1922), Diagnostic Substances (53)
Suggest a tag

Abaxis, Inc. At A Glance

Current Price: $23.91
Last Trade Time: 7/23/2008 4:00 PM
Open: $23.33
Previous Close: $23.32
Daily Range: $23.25 - $24.05
52-Week Range: $17.54 - $40.00
Volume: 405,329
Market Cap: $507.63M
P/E Ratio: 40.21
Compare Our Special Broker Offers!

Stock Trends

ABAX VS S&P 500 (SPY)

ABAX 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for ABAX

More Headlines...

Top Bull Pitch

Recs

1

Abaxis, Inc. (ABAX)

Avatar longshort87 (< 20) Submitted: 1/06/08 2:50 PM

Abaxis has a solid niche in the veterinary point-of-care diagnostics business augmented by an open-ended growth opportunity in human point-of-care diagnostics thanks to its unique Piccolo Xpress machine. The business model is classic razor-and-blade, with the machines (razors) selling at about a 50...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Abaxis, Inc. (ABAX)

Avatar brent2112 (46.77) Submitted: 1/12/07 12:44 PM

Abaxis has seen its glory days. I've watched this stock climb from $4-5 per share up to over $20. Unless they come up with something new, they will be relying on their reagent discs to supply income.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 23 :   1 2 3 4 5 Next »

Recs

0

 (ABAX)

Avatar lonewulf47638 (65.57) Submitted: 7/17/08 12:40 PM : Outperform Start Price: $22.94 ABAX Score: 1.32

LOOK for good earnings this month. Firess and disasters will increase demand for their blood test equipment.A disaster is about to happen this summer.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABAX)

Avatar stockworldpicks (38.28) Submitted: 6/04/08 6:39 PM : Outperform Start Price: $29.64 ABAX Score: -11.73

Abaxis Inc is a medical equipment company that sells Piccolo blood test machines. The company has greatly increased numbers and created long term contracts through point of sale. The company sells its machines primarily in the United States and also has a presence in Japan through a distribution deal.





According to the October 29th issue of Forbes magazine the company closed deals with 60% of MDs that it attempted to sell to. The Piccolo machines sell for $15,000 and use discs exclusively sold by Abaxis which provides a nice revenue stream. The number of offices with the machine was at .2% in this article. At the time of publication the company was just entering the veterinary field as well.





Forbes named Abaxis #11 in its annual best small companies in 2007. Previously in 2006 the company was listed at 25. Perhaps the biggest honor was Abaxis's CEO named entrepreneur of the year by Forbes for 2007.





Abaxis has a market cap of between $500 million and $750 million currently which makes it a growing small cap with plenty of room to grow. The company has no debt on its books. The company is represented in the S&P 600 Smallcap and S&P 1500 Supercomp.





A new machine was launched in September of 2007 called the HM5. The company just announced record sales for both the 3rd and 4th quarters of fiscal 2008. The discs used for the machines are being sold at a higher price and are recognized at a lower cost to make which will increase profit margins over the next year substantially. International sales make up 16% of the company's sales.





Abaxis sold 32 instruments at the North American Veterinarian Conference. The company sold 105 Piccolo human blood test machines in the month of Decmeber 2007. Eight hundred and eighty instruments total in the third quarter of 2008 and has the capacity to make 1000 instruments a quarter now and an unlimited potential with the addition of new vendors according to the conference call for the third quarter.





The company said they had a goal of $1 per share in earnings for fiscal 2008. I see them exceeding this and creating great shareholder value by producing more disks and tapping the international market. They also had announced that they planned to explore heartworm tests on animals using their machines. Shares have been as high as $40 the past 52 weeks. The shares are currently at $29.41 in after hours trading. I have a price target of $45 by 07/01/10.





Please check out my blog at:





http://stockworldpicks.blogspot.com

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABAX)

Avatar garyedd (61.23) Submitted: 5/28/08 9:37 PM : Outperform Start Price: $28.82 ABAX Score: -9.25

Serves both lower cost clinics with blood testing equipment and also pets/veteranarian market with similar products. Razor/razor blade model as blood reagent sales exceed machine sales, and each new customer sets up profitable long term repeat business. Highest profit segment now growing fastest. Also provides more tests faster and cheaper than

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABAX)

Avatar theinsideskinny (69.33) Submitted: 5/11/08 8:22 PM : Outperform Start Price: $25.66 ABAX Score: 1.11

This is a good trading stock with very good fundamentals behind it. It has started an upward movement from $22 and I am watching the technicals to make sure there is some momentum behind this move. Beta is 1.45 so it can get some good moves with the market. Looking for it to go back to the 52 week high of $40.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABAX)

Avatar LetterA (96.78) Submitted: 4/06/08 2:58 AM : Outperform Start Price: $24.82 ABAX Score: 3.37

Testing a portfolio of companies that start with the letter "A".

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 23 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 3 of 3  

picks per page. CHANGE

Top
Pick		Member NameMember RatingStart
Date		CallTime FrameStart
Price		Stock
Gain		S&P
Gain		ScorePitch
TrackJimCramer 81.15 01/17/08 01/17/08 Underperform 3W $37.05-35.47%-3.91%+31.55
TrackSunTrustRH 81.34 10/04/07 10/04/07 Outperform NS $24.54-2.57%-16.81%+14.24
TrackCLKing < 20 02/02/07 02/02/07 Outperform NS $22.03+8.53%-11.40%+19.93

Results 1 - 3 of 3  

X

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners